{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:46:53Z","timestamp":1777355213393,"version":"3.51.4"},"reference-count":20,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":869,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Blood Cancer"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1002\/pbc.24525","type":"journal-article","created":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T16:23:48Z","timestamp":1366043028000},"page":"E85-E87","source":"Crossref","is-referenced-by-count":21,"title":["Frequent mutations in<i>SH2D1A<\/i>(XLP) in males presenting with high-grade mature B-cell neoplasms"],"prefix":"10.1002","volume":"60","author":[{"given":"J.T.","family":"Sandlund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A.","family":"Shurtleff","sequence":"additional","affiliation":[{"name":"Department of Pathology; St. Jude Children's Research Hospital; Memphis, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Onciu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Howard","sequence":"additional","affiliation":[{"name":"Department of Immunology; St. Jude Children's Research Hospital; Memphis, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rencher","sequence":"additional","affiliation":[{"name":"Department of Oncology; St. Jude Children's Research Hospital; Memphis, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"Conley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,4,15]]},"reference":[{"key":"10.1002\/pbc.24525-BIB0001|pbc24525-cit-0001","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM197711172972001","article-title":"Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome","volume":"297","author":"Purtilo","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1002\/pbc.24525-BIB0002|pbc24525-cit-0002","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(75)92004-8","article-title":"X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)","volume":"1","author":"Purtilo","year":"1975","journal-title":"Lancet"},{"key":"10.1002\/pbc.24525-BIB0003|pbc24525-cit-0003","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.0105-2896.2005.00230.x","article-title":"Molecular and cellular pathogenesis of X-linked lymphoproliferative disease","volume":"203","author":"Nichols","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1002\/pbc.24525-BIB0004|pbc24525-cit-0004","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.clim.2006.02.005","article-title":"X-linked lymphoproliferative syndrome: An X-cellent question","volume":"119","author":"Filipovich","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1002\/pbc.24525-BIB0005|pbc24525-cit-0005","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood-2010-03-275909","article-title":"X-linked lymphoproliferative syndromes: Brothers or distant cousins","volume":"116","author":"Filipovich","year":"2010","journal-title":"Blood"},{"key":"10.1002\/pbc.24525-BIB0006|pbc24525-cit-0006","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1182\/blood.V98.5.1321","article-title":"Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome","volume":"98","author":"Morra","year":"2001","journal-title":"Blood"},{"key":"10.1002\/pbc.24525-BIB0007|pbc24525-cit-0007","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1203\/00006450-199510000-00001","article-title":"X-linked lymphoproliferative disease: Twenty-five years after the discovery","volume":"38","author":"Seemayer","year":"1995","journal-title":"Pediatr Res"},{"key":"10.1002\/pbc.24525-BIB0008|pbc24525-cit-0008","first-page":"3118","article-title":"Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease","volume":"96","author":"Sumegi","year":"2000","journal-title":"Blood"},{"key":"10.1002\/pbc.24525-BIB0009|pbc24525-cit-0009","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/hmg\/8.13.2407","article-title":"Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP)","volume":"8","author":"Brandau","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1002\/pbc.24525-BIB0010|pbc24525-cit-0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00277-002-0490-3","article-title":"Analysis of SH2D1A mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma","volume":"81","author":"Parolini","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1002\/pbc.24525-BIB0011|pbc24525-cit-0011","first-page":"149","article-title":"X-linked lymphoproliferative syndrome provides clues to the pathogenesis of Epstein-Barr virus-induced lymphomagenesis","volume":"18","author":"Purtilo","year":"1987","journal-title":"Princess Takamatsu Symp"},{"key":"10.1002\/pbc.24525-BIB0012|pbc24525-cit-0012","first-page":"A1868","article-title":"Absence of mutation in 62 Burkitt lymphoma cell lines","volume":"65","author":"Yin","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1002\/pbc.24525-BIB0013|pbc24525-cit-0013","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"10.1002\/pbc.24525-BIB0014|pbc24525-cit-0014","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1002\/pbc.24525-BIB0015|pbc24525-cit-0015","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0140-6736(93)91413-G","article-title":"Correction of Duncan's syndrome by allogeneic bone marrow transplantation","volume":"342","author":"Williams","year":"1993","journal-title":"Lancet"},{"key":"10.1002\/pbc.24525-BIB0016|pbc24525-cit-0016","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1073\/pnas.95.23.13765","article-title":"Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome","volume":"95","author":"Nichols","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/pbc.24525-BIB0017|pbc24525-cit-0017","first-page":"332","article-title":"Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: Dissimilarities from lymphomas in adults","volume":"7","author":"Murphy","year":"1980","journal-title":"Sem Oncol"},{"key":"10.1002\/pbc.24525-BIB0018|pbc24525-cit-0018","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.1986.4.12.1732","article-title":"Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine","volume":"4","author":"Murphy","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.24525-BIB0019|pbc24525-cit-0019","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","article-title":"Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: It is possible to reduce treatment for the early responding patients","volume":"109","author":"Patte","year":"2007","journal-title":"Blood"},{"key":"10.1002\/pbc.24525-BIB0020|pbc24525-cit-0020","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","article-title":"The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: Highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia","volume":"97","author":"Patte","year":"2001","journal-title":"Blood"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.24525","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pbc.24525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T11:37:27Z","timestamp":1625398647000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.24525"}},"subtitle":["<i>SH2D1A<\/i>Mutations in Males With B-NHL"],"short-title":[],"issued":{"date-parts":[[2013,4,15]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.24525","relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4,15]]}}}